FASTgraphs

Demystifying the Amazon Valuation Dilemma

Introduction Amazon: the Valuation Dark Side It is no secret that Amazon (AMZN) has been a disruptive force, especially relating to the retail sector.  On the other hand, the company is also an enigma to the value focused fundamental investor such as yours truly.  Over its entire operating history as a publicly traded company, Amazon …

The Active versus Passive Performance Debate Is Nonsensical

Introduction One of the most hotly contested debates in finance is the argument over which is better – active or passive investing.  Moreover, this debate has spurred numerous academic studies that claim to identify whether passive outperforms active investing or vice versa.  As a result, the current popular opinion suggests that passive outperforms active investing …

The Most Important Stock Investment Lesson I Ever Learned

Introduction My investing career officially started in 1970.  However, for several years prior to that time I was an avid and interested student of common stock investing.  My initial lessons were taught by studying the behavior and practices of the most renowned stock investors.  Although these academic pursuits taught me a great deal, nothing taught …

Pfizer Inc. Invest For Attractive Valuation and The 4% Dividend Yield

Investment Thesis Pfizer Inc (PFE) is one of the world’s largest pharmaceutical firms with sales exceeding $50 billion.  The company is currently attractively valued at a blended P/E ratio of 13.3, offering a current dividend yield of 4%.  Pfizer is awarded an S&P credit rating of AA and possesses a modest debt to capital ratio …

Celgene: A Primer on Growth Stock Value Investing (GARP): Part 2

Introduction This article is the second in a two-part series on applying the principles of value investing.  In part 1 found here my primary focus was on the benefits of investing in fundamentally strong dividend growth stocks when they are out of favor, and therefore, undervalued as a result.  In this part 2, I will …